3D Cell Culture Market , by Product [Bioreactors, Gels, Microchips, Scaffold-Free Platforms, Scaffold-Based Platforms (Macro-Porous, Micro-Porous, Nano-Porous, and Solid Scaffolds) and Services], by Application (Cancer Research, Drug Discovery, Regenerative Medicine, Stem Cell Research), by End Use (Academic Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Laboratories) Regional Analysis (North America, Europe, Asia-Pacific, LAMEA) Global Opportunity Analysis and Industry Forecast, 2019–2026
- RES4072062
- 145 Pages
- February 2020
- Healthcare
3D cell culture is primarily used to understand disease models and the impact of clinical drugs and. For example, liver cell spheroid 3D culture is mainly utilized for investigating drug induced liver injury, diseases and function. This reduces the requirement for 2D models and animal models. 3D cell culture has major applications in medicine tissue engineering and regenerative tissue engineering.
Globally, increasing awareness of cancerous diseases such as lung cancer, skin cancer, and others, is one of the major factors to drive the growth 3D cell culture market. 3D Cell culture is the crucial part of oncology because it is involved in the understanding of the physiology of the cells and clinical trials.
However, higher cost of technologies and lack of skilled professionals will decline the 3D cell culture industry.
With new advances, 3D composite scaffolds have many versatile properties. It will be tremendously useful to develop treatments for nerve disorders and spinal cord injury (SCI) by taking help of cell transplantation methodologies and biomaterials. The most remarkable advantage of 3D cell culture is that its properties can be easily adapted by modifying the structure and composition. These key factors of 3D cell culture are projected to create lucrative opportunities for the growth of 3D cell culture market.
On the basis of product, the global market is broadly fragmented into microchips, gels, scaffold-based platforms, bioreactors, Scaffold-Free Platforms, and Services.
Microchips segment is projected to boost at a healthy CAGR rate, and is projected to surpass $2,515.1 million by 2026, growing from $305.5 million in 2018. The integration of microchips provides advances in wide-ranging fields such as, basic biological research, diagnostics and others. These aforementioned, elements are projected to upsurge the market of 3d cell culture.
By application, the market is segmented into cancer research, drug discovery, regenerative medicine, stem cell research. Cancer research size will witness a major growth and is projected to cross $4,057.1 million by 2026, during the forecasted period. extensive growth in geriatric population is projected foster the demand for 3d cell culture market.
3D cell culture market for North America is projected to drive at a CAGR of 28.1% by registering a revenue of $4,019.1 million by 2026. 3D cell culture offers predictive results of in-vivo tests.
3D cell culture market for Asia-Pacific is projected to generate a revenue of $353.7 million in 2018 and is expected to cross $3,020.7 million by 2026. This region possesses significant market potential for the 3D cell culture market because of increase in drug discoveries.
Some of the major 3D Cell Culture market players include Thermo Fisher Scientific, Corning Incorporated, 3D Biotek, TissUse GmbH, Hµrel Corporation, SynVivo, Advanced BioMatrix, QGel SA, Lonza and Greiner Bio-One International. Market Players prefer inorganic growth strategies to expand into local markets. 3D Cell Culture market players are more emphasizing on Merger & acquisition and advanced product development. These are the frequent strategies followed by the established organizations.
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Product Trends
2.3. Application Trends
2.4. End Use Trends
3. Market Overview
3.1. Market segmentation & definitions
3.2. Key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Pricing overview
3.8.1. By Product Type
3.8.2. By Application
3.8.3. By End Use
3.9. Market value chain analysis
3.9.1. Stress point analysis
3.9.2. Raw material analysis
3.9.3. Manufacturing process
3.9.4. Distribution channel analysis
3.9.5. Operating vendors
3.9.5.1. Raw material suppliers
3.9.5.2. Product manufacturers
3.9.5.3. Product distributors
3.10. Strategic overview
4. 3D Cell Culture Market, by Product Type
4.1. Bioreactors
4.1.1. Market size and forecast, by region, 2018-2026
4.1.2. Comparative market share analysis, 2018 & 2026
4.2. Gels
4.2.1. Market size and forecast, by region, 2018-2026
4.2.2. Comparative market share analysis, 2018 & 2026
4.3. Microchips
4.3.1. Market size and forecast, by region, 2018-2026
4.3.2. Comparative market share analysis, 2018 & 2026
4.4. Scaffold-Free Platforms
4.4.1. Market size and forecast, by region, 2018-2026
4.4.2. Comparative market share analysis, 2018 & 2026
4.5. Scaffold-Based Platforms
4.5.1. Market size and forecast, by region, 2018-2026
4.5.2. Comparative market share analysis, 2018 & 2026
4.5.2.1. Macro-Porous
4.5.2.1.1. Market size and forecast, by region, 2018-2026
4.5.2.1.2. Comparative market share analysis, 2018 & 2026
4.5.2.2. Micro-Porous
4.5.2.2.1. Market size and forecast, by region, 2018-2026
4.5.2.2.2. Comparative market share analysis, 2018 & 2026
4.5.2.3. Nano-Porous
4.5.2.3.1. Market size and forecast, by region, 2018-2026
4.5.2.3.2. Comparative market share analysis, 2018 & 2026
4.5.2.4. Solid Scaffolds
4.5.2.4.1. Market size and forecast, by region, 2018-2026
4.5.2.4.2. Comparative market share analysis, 2018 & 2026
4.6. Services
4.6.1. Market size and forecast, by region, 2018-2026
4.6.2. Comparative market share analysis, 2018 & 2026
5. 3D Cell Culture Market, by Application
5.1. Cancer Research
5.1.1. Market size and forecast, by region, 2018-2026
5.1.2. Comparative market share analysis, 2018 & 2026
5.2. Drug Discovery
5.2.1. Market size and forecast, by region, 2018-2026
5.2.2. Comparative market share analysis, 2018 & 2026
5.3. Regenerative Medicine
5.3.1. Market size and forecast, by region, 2018-2026
5.3.2. Comparative market share analysis, 2018 & 2026
5.4. Stem Cell Research
5.4.1. Market size and forecast, by region, 2018-2026
5.4.2. Comparative market share analysis, 2018 & 2026
6. 3D Cell Culture Market, by End Use
6.1. Academic Institutes
6.1.1. Market size and forecast, by region, 2018-2026
6.1.2. Comparative market share analysis, 2018 & 2026
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Market size and forecast, by region, 2018-2026
6.2.2. Comparative market share analysis, 2018 & 2026
6.3. Contract Research Laboratories
6.3.1. Market size and forecast, by region, 2018-2026
6.3.2. Comparative market share analysis, 2018 & 2026
7. 3D Cell Culture Market, by Region
7.1. North America
7.1.1. Market size and forecast, by Product type, 2018-2026
7.1.2. Market size and forecast, by application, 2018-2026
7.1.3. Market size and forecast, by end use, 2018-2026
7.1.4. Market size and forecast, by country, 2018-2026
7.1.5. Comparative market share analysis, 2018 & 2026
7.1.6. U.S.
7.1.6.1. Market size and forecast, by product type, 2018-2026
7.1.6.2. Market size and forecast, by application, 2018-2026
7.1.6.3. Market size and forecast, by end use, 2018-2026
7.1.6.4. Comparative market share analysis, 2018 & 2026
7.1.7. Canada
7.1.7.1. Market size and forecast, by Product type, 2018-2026
7.1.7.2. Market size and forecast, by application, 2018-2026
7.1.7.3. Market size and forecast, by end ese, 2018-2026
7.1.7.4. Comparative market share analysis, 2018 & 2026
7.2. Europe
7.2.1. Market size and forecast, by product type, 2018-2026
7.2.2. Market size and forecast, by application, 2018-2026
7.2.3. Market size and forecast, by end use, 2018-2026
7.2.4. Market size and forecast, by country, 2018-2026
7.2.5. Comparative market share analysis, 2018 & 2026
7.2.6. Germany
7.2.6.1. Market size and forecast, by product type, 2018-2026
7.2.6.2. Market size and forecast, by application, 2018-2026
7.2.6.3. Market size and forecast, by end use, 2018-2026
7.2.6.4. Comparative market share analysis, 2018 & 2026
7.2.7. UK
7.2.7.1. Market size and forecast, by product type, 2018-2026
7.2.7.2. Market size and forecast, by application, 2018-2026
7.2.7.3. Market size and forecast, by end use, 2018-2026
7.2.7.4. Comparative market share analysis, 2018 & 2026
7.2.8. France
7.2.8.1. Market size and forecast, by product type, 2018-2026
7.2.8.2. Market size and forecast, by application, 2018-2026
7.2.8.3. Market size and forecast, by end use, 2018-2026
7.2.8.4. Comparative market share analysis, 2018 & 2026
7.2.9. Spain
7.2.9.1. Market size and forecast, by product type, 2018-2026
7.2.9.2. Market size and forecast, by application, 2018-2026
7.2.9.3. Market size and forecast, by end use, 2018-2026
7.2.9.4. Comparative market share analysis, 2018 & 2026
7.2.10. Italy
7.2.10.1. Market size and forecast, by product type, 2018-2026
7.2.10.2. Market size and forecast, by application, 2018-2026
7.2.10.3. Market size and forecast, by end use, 2018-2026
7.2.10.4. Comparative market share analysis, 2018 & 2026
7.2.11. Rest of Europe
7.2.11.1. Market size and forecast, by product type, 2018-2026
7.2.11.2. Market size and forecast, by application, 2018-2026
7.2.11.3. Market size and forecast, by end use, 2018-2026
7.2.11.4. Comparative market share analysis, 2018 & 2026
7.3. Asia Pacific
7.3.1. Market size and forecast, by product type, 2018-2026
7.3.2. Market size and forecast, by application, 2018-2026
7.3.3. Market size and forecast, by end use, 2018-2026
7.3.4. Market size and forecast, by country, 2018-2026
7.3.5. Comparative market share analysis, 2018 & 2026
7.3.6. China
7.3.6.1. Market size and forecast, by product type, 2018-2026
7.3.6.2. Market size and forecast, by application, 2018-2026
7.3.6.3. Market size and forecast, by end use, 2018-2026
7.3.6.4. Comparative market share analysis, 2018 & 2026
7.3.7. India
7.3.7.1. Market size and forecast, by product type, 2018-2026
7.3.7.2. Market size and forecast, by application, 2018-2026
7.3.7.3. Market size and forecast, by end use, 2018-2026
7.3.7.4. Comparative market share analysis, 2018 & 2026
7.3.8. Australia
7.3.8.1. Market size and forecast, by product type, 2018-2026
7.3.8.2. Market size and forecast, by application, 2018-2026
7.3.8.3. Market size and forecast, by end use, 2018-2026
7.3.8.4. Comparative market share analysis, 2018 & 2026
7.3.9. Rest of Asia Pacific
7.3.9.1. Market size and forecast, by product type, 2018-2026
7.3.9.2. Market size and forecast, by application, 2018-2026
7.3.9.3. Market size and forecast, by end use, 2018-2026
7.3.9.4. Comparative market share analysis, 2018 & 2026
7.4. LAMEA
7.4.1. Market size and forecast, by product type, 2018-2026
7.4.2. Market size and forecast, by application, 2018-2026
7.4.3. Market size and forecast, by end use, 2018-2026
7.4.4. Market size and forecast, by country, 2018-2026
7.4.5. Comparative market share analysis, 2018 & 2026
7.4.6. Latin America
7.4.6.1. Market size and forecast, by product type, 2018-2026
7.4.6.2. Market size and forecast, by application, 2018-2026
7.4.6.3. Market size and forecast, by end use, 2018-2026
7.4.6.4. Comparative market share analysis, 2018 & 2026
7.4.7. Middle East
7.4.7.1. Market size and forecast, by product type, 2018-2026
7.4.7.2. Market size and forecast, by application, 2018-2026
7.4.7.3. Market size and forecast, by end use, 2018-2026
7.4.7.4. Comparative market share analysis, 2018 & 2026
7.4.8. Africa
7.4.8.1. Market size and forecast, by product type, 2018-2026
7.4.8.2. Market size and forecast, by application, 2018-2026
7.4.8.3. Market size and forecast, by end use, 2018-2026
7.4.8.4. Comparative market share analysis, 2018 & 2026
8. Company Profiles
8.1. Corning Incorporated
8.1.1. Business overview
8.1.2. Financial performance
8.1.3. Product portfolio
8.1.4. Recent strategic moves & developments
8.1.5. SWOT analysis
8.2. Thermo Fisher Scientific
8.2.1. Business overview
8.2.2. Financial performance
8.2.3. Product portfolio
8.2.4. Recent strategic moves & developments
8.2.5. SWOT analysis
8.3. TissUse GmbH
8.3.1. Business overview
8.3.2. Financial performance
8.3.3. Product portfolio
8.3.4. Recent strategic moves & developments
8.3.5. SWOT analysis
8.4. 3D Biotek
8.4.1. Business overview
8.4.2. Financial performance
8.4.3. Product portfolio
8.4.4. Recent strategic moves & developments
8.4.5. SWOT analysis
8.5. Hµrel Corporation
8.5.1. Business overview
8.5.2. Financial performance
8.5.3. Product portfolio
8.5.4. Recent strategic moves & developments
8.5.5. SWOT analysis
8.6. QGel SA
8.6.1. Business overview
8.6.2. Financial performance
8.6.3. Product portfolio
8.6.4. Recent strategic moves & developments
8.6.5. SWOT analysis
8.7. SynVivo
8.7.1. Business overview
8.7.2. Financial performance
8.7.3. Product portfolio
8.7.4. Recent strategic moves & developments
8.7.5. SWOT analysis
8.8. Advanced BioMatrix
8.8.1. Business overview
8.8.2. Financial performance
8.8.3. Product portfolio
8.8.4. Recent strategic moves & developments
8.8.5. SWOT analysis
8.9. Greiner Bio-One International
8.9.1. Business overview
8.9.2. Financial performance
8.9.3. Product portfolio
8.9.4. Recent strategic moves & developments
8.9.5. SWOT analysis
8.10. Lonza
8.10.1. Business overview
8.10.2. Financial performance
8.10.3. Product portfolio
8.10.4. Recent strategic moves & developments
8.10.5. SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
